Akèy › Glomeruloskleroz fokal segmantè › Michigan › Ann Arbor
Etid klinik pou Glomeruloskleroz fokal segmantè nan Ann Arbor, MI
6 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Ap rekriteFaz 2
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
Nephrotic Syndrome Study Network
Ap rekriteEtid obsèvasyon
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Ap rekriteFaz 2
- C.S. Mott Children's Hospital, Ann Arbor
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
Ap rekriteEtid obsèvasyon
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Ap rekriteFaz 3
- University of Michigan, Ann Arbor
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Ap rekriteEtid obsèvasyon
- University of Michigan, Ann Arbor
Etid Glomeruloskleroz fokal segmantè nan lòt vil
- Philadelphia, PA9 etid
- Durham, NC8 etid
- New York City, NY7 etid
- Queens, NY6 etid
- Miami, FL6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Atlanta, GA5 etid
- Cleveland, OH4 etid
- Chicago, IL4 etid
- Dallas, TX4 etid
- Kansas City, MO4 etid
Lòt etid nan Ann Arbor
- Kansè pwostat27 etid
- Kansè nan tete26 etid
- Kansè Poumon ki pa ti selil26 etid
- Kansè (tout kalite)25 etid
- Kansè kolorektal23 etid
- Kansè poumon23 etid
- Ensifizyans kadyak22 etid
- Leksemi mieloïd egi17 etid
- Maladi kadyovaskilè16 etid
- Kansè pankreyas14 etid
- Melanom12 etid
- Kansè renn (Kasinom selil renn)12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.